Covid-19 Vaccine Candidate

Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said.

A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.

Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US.

India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.

Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.

Japan's minister in charge of COVID-19 vaccinations is seen as the most suitable candidate to become the next prime minister, while a female former internal affairs minister has secured backing for her bid for the top job, media reported on Sunday.

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.

Scientists have developed a protein-based COVID-19 vaccine candidate that mimics the shape of the virus to trigger robust antibody response in animals.

Four COVID-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday.

Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.

Scientists at the Institute of Life Sciences (ILS) in Bhubaneshwar have developed animal models and a modern laboratory that will help in testing and evaluation of drugs and vaccine candidates for the novel coronavirus.

There are more than 10 effective Covid-19 vaccines in use around the world, so it's easy to forget those still in development. That's a mistake. These candidates may be taking longer to arrive, but they're essential to the pandemic fight.

Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.

Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.

There are seven more COVID-19 vaccine candidates in various stages of clinical trials, and a further two dozen in pre-clinical trials, Union Health Minister Dr Harsh Vardhan said Tuesday afternoon, as he and his wife got their second dose of Covaxin

Bharat Biotech, which is working on an intranasal COVID-19 vaccine candidate is hopeful of getting regulatory licenses this month, if all goes well, Chairman and Managing Director of BBIL, Krishna Ella said.

A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.

Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US.

India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.

Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.

Japan's minister in charge of COVID-19 vaccinations is seen as the most suitable candidate to become the next prime minister, while a female former internal affairs minister has secured backing for her bid for the top job, media reported on Sunday.

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.

Scientists have developed a protein-based COVID-19 vaccine candidate that mimics the shape of the virus to trigger robust antibody response in animals.

Four COVID-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday.

Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.

Scientists at the Institute of Life Sciences (ILS) in Bhubaneshwar have developed animal models and a modern laboratory that will help in testing and evaluation of drugs and vaccine candidates for the novel coronavirus.

There are more than 10 effective Covid-19 vaccines in use around the world, so it's easy to forget those still in development. That's a mistake. These candidates may be taking longer to arrive, but they're essential to the pandemic fight.

Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.

Pune-based Gennova Biopharmaceuticals has initiated the enrolment of volunteers for Phase 1/2 clinical trials for its mRNA vaccine candidate HGCO19, said the Department of Biotechnology, which provided seed funding for its development, on Tuesday.

There are seven more COVID-19 vaccine candidates in various stages of clinical trials, and a further two dozen in pre-clinical trials, Union Health Minister Dr Harsh Vardhan said Tuesday afternoon, as he and his wife got their second dose of Covaxin